Tel: 01892 526726     Email:     Twitter

Dedicated to providing an
outstanding level of care

Quality Assurance

WKG is committed to providing an outstanding level of care, and we are confident in our ability to provide you with a service that is friendly, modern and prompt. Not only is Dr. Harris accountable to the NHS-led principles of clinical governance (see below), WKG has also developed further independent measures in order to evaluate patient satisfaction and respond to patient feedback.

What is clinical governance?

This is a body of measures designed for the purpose of evaluating and continually improving the quality of service provided by a healthcare organisation.

Clinical governance involves clinical audit and clinical effectiveness.

What is clinical audit?

This ensures that healthcare professionals’ performance is reviewed to ensure that they are providing and maintaining a high standard of care.

In 2014, Dr. Harris has participated in the following 3 clinical audits:

1) National clinical audit of biological therapies – UK IBD audit (IBD 077) – The British Society of Gastroenterology (BSG) and Royal College of Physicians (RCP) recommend that all patients receiving treatment with a biological agent (infliximab or adalimumab) are entered onto a confidential national database. Dr Harris and his team take part in this prospective quality assurance audit and have done so for the last 3 years.

2) NICE TA 187: Infliximab and adalimumab for the treatment of Crohn’s disease: a Re-audit (Audit ID No: 388/14/15) – NICE has published Quality Standards for the use of infliximab and adalimumab in patients with Crohn’s disease. It is recommended that consultants prescribing these drugs are monitored to ensure that the drugs are used in appropriate patients .

3) Prospective audit of the use of tacrolimus in patients with sub-acute ulcerative procto-colitis.
NICE Guidelines on the management of patients with ulcerative colitis recommend the use of tacrolimus in patients whom fail to respond to mesalazine, steroids or thiopurines and who do not wish to undergo surgery. Dr Harris has been recommending this drug since 2010 and, to date, has used it in over 40 patients. An audit of its safety, tolerability and effectiveness was presented to the BSG in June 2014.

What is clinical effectiveness?

This involves measuring performance in line with certain standards (see Table) and assessing patients’ views of the service.

Table: Quality Assurance in Endoscopy

Procedure  British Society of Gastroenterology Standards Dr Harris’ Performance (December 2015) Dr Harris’ Performance (December 2016)
Upper GI Endoscopy Min. number of procedures = 100
Intubation success (95%)
Procedure-related complications
30 day procedure-related mortality
NHS 234; private 245
NHS 125; private 236
Flexible Sigmoidoscopy Min. number of procedures = 50
Procedure- related complications
30 day procedure-related mortality
NHS 151;  private 56
NHS 33;  private 103
 Colonoscopy Min. number of procedures = 100
Completion (>90%)
Adenoma detection rates (15%)
Retrieval rates of polyps (>90%)
Procedure related complications
30 day procedure-related mortality
NHS 221; private 119
NHS 141; private 154

This table demonstrates that Dr Harris’ endoscopic skills meet or exceed the standards set by the BSG.

What further measures of clinical governance does West Kent Gastroenterology provide?

WKG is unique in providing an online quality assurance survey to a random selection of patients after the final consultation to evaluate the overall service. This is to ensure that a very high quality is consistently maintained across all areas of the practice. Any complaints or compliments are discussed, considered carefully, and when necessary, changes in practice follow.

We are delighted to report that:

100% of patients would recommend (or have already recommended) WKG’s service to others;

95% of patients felt that WKG provided them with a prompt, friendly and modern service from start to finish.

[information correct as of 1st September 2017]